| Literature DB >> 7495490 |
M Tary-Lehmann1, A Saxon, P V Lehmann.
Abstract
Severe combined immunodeficiency (SCID) mice can be stably grafted with human peripheral blood lymphocytes, creating hu-PBL-SCID chimeras; essentially, these are mice with a human immune system. Here, Magdalena Tary-Lehmann, Andrew Saxon and Paul Lehmann discuss the immunobiology of these chimeras. The authors propose that hu-PBL-SCID chimerism evolves in two phases. During the first three weeks after grafting, many of the injected cells survive and the human immune system is functional. Subsequently, anti-mouse-reactive clones are selected and the immune system becomes nonfunctional. The implications of this scenario for the utilization of the hu-PBL-SCID model are discussed.Entities:
Mesh:
Year: 1995 PMID: 7495490 DOI: 10.1016/0167-5699(95)80046-8
Source DB: PubMed Journal: Immunol Today ISSN: 0167-5699